Patents by Inventor Rekha S. Patel

Rekha S. Patel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PKC-Delta-I inhibitor formulations and uses thereof
    Patent number: 11844779
    Abstract: Provided herein are formulations that can contain an effective amount of a PKC? inhibitor. Also provided herein are methods of inhibiting a PKC? in a subject in need thereof, that can include the step of administering an effective amount of a compound that is capable of inhibiting a PKC?.
    Type: Grant
    Filed: September 13, 2021
    Date of Patent: December 19, 2023
    Assignees: UNIVERSITY OF SOUTH FLORIDA, THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS
    Inventors: Niketa A. Patel, Rekha S. Patel, Robert Pleasants Sparks, Wayne Charles Guida
  • PKC-DELTA-I INHIBITOR FORMULATIONS AND USES THEREOF
    Publication number: 20210401802
    Abstract: Provided herein are formulations that can contain an effective amount of a PKC? inhibitor. Also provided herein are methods of inhibiting a PKC? in a subject in need thereof, that can include the step of administering an effective amount of a compound that is capable of inhibiting a PKC?.
    Type: Application
    Filed: September 13, 2021
    Publication date: December 30, 2021
    Inventors: NIKETA A. PATEL, REKHA S. PATEL, ROBERT PLEASANTS SPARKS, WAYNE CHARLES GUIDA
  • PKC-delta-I inhibitor formulations and uses thereof
    Patent number: 11129808
    Abstract: Provided herein are formulations that can contain an effective amount of a PKC? inhibitor. Also provided herein are methods of inhibiting a PKC? in a subject in need thereof, that can include the step of administering an effective amount of a compound that is capable of inhibiting a PKC?.
    Type: Grant
    Filed: March 15, 2017
    Date of Patent: September 28, 2021
    Assignees: UNIVERSITY OF SOUTH FLORIDA, THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERRANS AFFAIRS OFFICE OF THE GENERAL COUNSEL
    Inventors: Niketa A. Patel, Rekha S. Patel, Robert Pleasants Sparks, Wayne Charles Guida
  • PKC-DELTA-I INHIBITOR FORMULATIONS AND USES THEREOF
    Publication number: 20190091201
    Abstract: Provided herein are formulations that can contain an effective amount of a PKC? inhibitor. Also provided herein are methods of inhibiting a PKC? in a subject in need thereof, that can include the step of administering an effective amount of a compound that is capable of inhibiting a PKC?.
    Type: Application
    Filed: March 15, 2017
    Publication date: March 28, 2019
    Applicant: University of South Florida
    Inventors: NIKETA A. PATEL, REKHA S. PATEL, ROBERT PLEASANTS SPARKS, WAYNE CHARLES GUIDA
  • Compositions and methods for adipocyte modulation
    Patent number: 9458086
    Abstract: Modified stilbenoids and formulations thereof are provided. The modified stilbenoids can include one or more amino or amino-alkyl substituents. The formulation can be for the treatment or prevention of obesity and the modified stilbenoid present in an effective amount to alleviate or prevent the onset of one or more symptoms of obesity. Methods of making the modified stilbenoids and formulations thereof are provided. Methods are provided for treating a subject with a modified stilbenoid in an effective amount to alleviate or prevent one or more symptoms associated with diabetes, cardiovascular disease, high blood pressure, deep vein thrombosis, osteoarthritis, obstructive sleep apnea, cancer, and non-alcoholic fatty liver disease. The administration of the modified stilbenoids can result in decreased levels of PKC?II, PKC?VIII, substantially unaltered expression of PKC?I; a decreased number of adipocytes; increased weight and/or fat loss; or a combination thereof.
    Type: Grant
    Filed: July 2, 2014
    Date of Patent: October 4, 2016
    Assignees: University of South Florida (A Florida Non-Profit Corporation), The United States of America as Represented by the Department of Veterans Affairs Office of General Counsel—PSG IV (024)
    Inventors: Niketa A. Patel, Rekha S. Patel, Kirpal S. Bisht
  • USE OF PKC ISOZYMES FOR DIAGNOSIS AND TREATMENT OF NEUROBLASTOMA
    Publication number: 20120141498
    Abstract: The present invention pertains to the use of PKC-epsilon (PKC-?), PKC-delta (PKC-?), PKC-eta, and/or PKC-theta as biomarker(s) for prediction and/or detection of neuroblastoma, as well as therapeutic targets for treatment of neuroblastoma.
    Type: Application
    Filed: December 2, 2011
    Publication date: June 7, 2012
    Applicants: United States Government as Represented by the Department of Veterans Affairs, University of South Florida
    Inventors: Mildred E. Acevedo-Duncan, Rekha S. Patel